Multiple Myeloma Therapeutics Clinical Trials Review, Q4, 2010
Publisher Name » GlobalData
Published Date » 2010-11-30
No. Of Pages » 92
GlobalData's clinical trial report, “Multiple Myeloma Global Clinical Trials Review, Q4, 2010""” provides data on the Multiple Myeloma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Multiple Myeloma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Multiple Myeloma.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 3
1.2 List of Figures 5
2 Introduction 6
2.1 Multiple Myeloma 6
2.2 Report Guidance 6
3 Clinical Trials by Region 7
3.1 Clinical Trials by Country 8
3.1.1 Top Five Countries Contributing to Clinical Trials in Europe 11
3.1.2 Top Countries Contributing to Clinical Trials in North America 12
3.1.3 Top Countries Contributing to Clinical Trials in Middle East and Africa 13
3.1.4 Top Countries Contributing to Clinical Trials in Central and South America 14
3.2 Clinical Trials by BRIC Countries 15
4 Clinical Trials by Phase 16
4.1 In Progress Trials by Phase 17
5 Clinical Trials by Trial Status 18
6 Unaccomplished Trials of Multiple Myeloma 19
7 Subjects Recruited Over a Period of Time 25
8 Prominent Sponsors 26
8.1 Top Ten Companies Participating in Multiple Myeloma Therapeutics Clinical Trials 27
9 Prominent Drug Comparison 29
10 Clinical Trial Profiles 30
10.1 Clinical Trial Overview of Top Companies 30
10.1.1 Celgene Corporation 30
10.1.2 Johnson & Johnson 32
10.1.3 Takeda Pharmaceutical Company Limited 34
10.1.4 Novartis Pharmaceuticals Corporation 36
10.1.5 Merck & Co., Inc. 37
10.1.6 Vaxil Bio Therapeutics Ltd. 38
10.1.7 Sanofi-Aventis 39
10.1.8 Onyx Pharmaceuticals, Inc. 40
10.1.9 Janssen Pharmaceutica N.V. 41
10.1.10 Bristol-Myers Squibb Company 42
10.1.11 Oncotherapeutics 43
10.1.12 Amgen Inc. 44
10.1.13 Cephalon, Inc. 45
10.1.14 Pfizer Inc. 46
10.1.15 Innate Pharma SA 47
10.1.16 Poniard Pharmaceuticals, Inc. 47
10.1.17 Pharmacyclics, Inc. 48
10.1.18 Immunovative Therapies, Ltd. 48
10.1.19 . Facet Biotech Corporation 49
10.1.20 ZIOPHARM Oncology, Inc. 49
11 Clinical Trial Profiles 50
11.1 Clinical Trial Overview of Top Institutes / Hospitals / Universities 50
11.1.1 National Cancer Institute (NCI) 50
11.1.2 The University of Texas M. D. Anderson Cancer Center 58
11.1.3 Fred Hutchinson Cancer Research Center-Technology Transfer 61
11.1.4 Mayo Clinic 65
11.1.5 University of Arkansas 67
11.1.6 Memorial Sloan Kettering Cancer Center 70
11.1.7 Sidney Kimmel Comprehensive Cancer Center 73
11.1.8 Roswell Park Cancer Institute 75
11.1.9 H. Lee Moffitt Cancer Center & Research Institute 76
11.1.10 Dana-Farber Cancer Institute 77
11.1.11 Southwest Oncology Group 78
11.1.12 University of California, San Francisco 80
11.1.13 Case Comprehensive Cancer Center 81
11.1.14 Eastern Cooperative Oncology Group 82
11.1.15 Barbara Ann Karmanos Cancer Institute 83
11.1.16 Beckman Research Institute 85
11.1.17 The Cancer and Leukemia Group B 86
11.1.18 Massachusetts General Hospital 87
11.1.19 The Vanderbilt-Ingram Cancer Center 88
11.1.20 National Heart, Lung, and Blood Institute 89
12 Appendix 90
12.1 Abbreviations 90
12.2 Definitions 90
12.3 Research Methodology 91
12.4 Secondary Research 91
12.5 About GlobalData 91
12.6 Contact Us 91
12.7 Disclaimer 92
12.8 Source 92
Table 1: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Zone, 1982-2010* 7
Table 2: Multiple Myeloma Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 1982-2010* 9
Table 3: Multiple Myeloma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 1982-2010* 10
Table 4: Multiple Myeloma Therapeutics Clinical Trials, Europe, Top Five Countries, 1982-2010* 11
Table 5: Multiple Myeloma Therapeutics Clinical Trials, North America, Top Five Countries, 1982-2010* 12
Table 6: Multiple Myeloma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 1982-2010* 13
Table 7: Multiple Myeloma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 1982-2010* 14
Table 8: Multiple Myeloma Therapeutics Clinical Trials, BRIC Countries, 1982-2010* 15
Table 9: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Phase, 1982-2010* 16
Table 10: Multiple Myeloma Therapeutics Market, Global, Clinical Trials in Progress by Phase 1982-2010* 17
Table 11: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Trial Status, 1982-2010* 18
Table 12: Multiple Myeloma Therapeutics Market, Global, Suspended Clinical Trials, 1982-2010* 19
Table 13: Multiple Myeloma Therapeutics Market, Global, Terminated Clinical Trials, 1982-2010* 20
Table 14: Multiple Myeloma Therapeutics Market, Global, Terminated Clinical Trials, 1982-2010* 24
Table 15: Multiple Myeloma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 25
Table 16: Multiple Myeloma Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Table 17: Multiple Myeloma Therapeutics Clinical Trials, Global, Top Ten Companies by Phase, 1982-2010* 28
Table 18: Multiple Myeloma Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 1982-2010* 29
Table 19: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 1982-2010* 30
Table 20: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 1982-2010* 32
Table 21: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 1982-2010* 34
Table 22: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 1982-2010* 36
Table 23: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 1982-2010* 37
Table 24: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vaxil Bio Therapeutics Ltd., 1982-2010* 38
Table 25: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 1982-2010* 39
Table 26: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Onyx Pharmaceuticals, Inc., 1982-2010* 40
Table 27: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceutica N.V., 1982-2010* 41
Table 28: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 1982-2010* 42
Table 29: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncotherapeutics, 1982-2010* 43
Table 30: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 1982-2010* 44
Table 31: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 1982-2010* 45
Table 32: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 1982-2010* 46
Table 33: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Innate Pharma SA , 1982-2010* 47
Table 34: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Poniard Pharmaceuticals, Inc., 1982-2010* 47
Table 35: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 1982-2010* 48
Table 36: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunovative Therapies, Ltd., 1982-2010* 48
Table 37: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Facet Biotech Corporation, 1982-2010* 49
Table 38: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM Oncology, Inc., 1982-2010* 49
Table 39: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 1982-2010* 50
Table 40: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 1982-2010* 58
Table 41: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 1982-2010* 61
Table 42: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 1982-2010* 65
Table 43: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 1982-2010* 67
Table 44: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 1982-2010* 70
Table 45: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 1982-2010* 73
Table 46: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 1982-2010* 75
Table 47: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 1982-2010* 76
Table 48: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 1982-2010* 77
Table 49: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 1982-2010* 78
Table 50: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 1982-2010* 80
Table 51: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 1982-2010* 81
Table 52: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 1982-2010* 82
Table 53: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 1982-2010* 83
Table 54: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beckman Research Institute, 1982-2010* 85
Table 55: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cancer and Leukemia Group B, 1982-2010* 86
Table 56: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 1982-2010* 87
Table 57: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Vanderbilt-Ingram Cancer Center, 1982-2010* 88
Table 58: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 1982-2010* 89
Figure 1: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Zone (%), 1982-2010* 7
Figure 2: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Top Countries, 1982-2010* 8
Figure 3: Multiple Myeloma Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 1982-2010* 9
Figure 4: Multiple Myeloma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 1982-2010* 10
Figure 5: Multiple Myeloma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 1982-2010* 11
Figure 6: Multiple Myeloma Therapeutics Clinical Trials, North America, Top Five Countries (%), 1982-2010* 12
Figure 7: Multiple Myeloma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 1982-2010* 13
Figure 8 : Multiple Myeloma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 1982-2010* 14
Figure 9: Multiple Myeloma Therapeutics Clinical Trials, BRIC Countries (%), 1982-2010* 15
Figure 10: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Phase (%), 1982-2010* 16
Figure 11: Multiple Myeloma Therapeutics Market, Global, Clinical Trials in Progress by Phase, 1982-2010* 17
Figure 12: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Trial Status, 1982-2010* 18
Figure 13 : Multiple Myeloma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 25
Figure 14: Multiple Myeloma Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Figure 15: Multiple Myeloma Therapeutics Clinical Trials, Global, Top Ten Companies by Phase, 1982-2010* 27
Figure 16: Multiple Myeloma Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 1982-2010* 29
1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 3
1.2 List of Figures 5
2 Introduction 6
2.1 Multiple Myeloma 6
2.2 Report Guidance 6
3 Clinical Trials by Region 7
3.1 Clinical Trials by Country 8
3.1.1 Top Five Countries Contributing to Clinical Trials in Europe 11
3.1.2 Top Countries Contributing to Clinical Trials in North America 12
3.1.3 Top Countries Contributing to Clinical Trials in Middle East and Africa 13
3.1.4 Top Countries Contributing to Clinical Trials in Central and South America 14
3.2 Clinical Trials by BRIC Countries 15
4 Clinical Trials by Phase 16
4.1 In Progress Trials by Phase 17
5 Clinical Trials by Trial Status 18
6 Unaccomplished Trials of Multiple Myeloma 19
7 Subjects Recruited Over a Period of Time 25
8 Prominent Sponsors 26
8.1 Top Ten Companies Participating in Multiple Myeloma Therapeutics Clinical Trials 27
9 Prominent Drug Comparison 29
10 Clinical Trial Profiles 30
10.1 Clinical Trial Overview of Top Companies 30
10.1.1 Celgene Corporation 30
10.1.2 Johnson & Johnson 32
10.1.3 Takeda Pharmaceutical Company Limited 34
10.1.4 Novartis Pharmaceuticals Corporation 36
10.1.5 Merck & Co., Inc. 37
10.1.6 Vaxil Bio Therapeutics Ltd. 38
10.1.7 Sanofi-Aventis 39
10.1.8 Onyx Pharmaceuticals, Inc. 40
10.1.9 Janssen Pharmaceutica N.V. 41
10.1.10 Bristol-Myers Squibb Company 42
10.1.11 Oncotherapeutics 43
10.1.12 Amgen Inc. 44
10.1.13 Cephalon, Inc. 45
10.1.14 Pfizer Inc. 46
10.1.15 Innate Pharma SA 47
10.1.16 Poniard Pharmaceuticals, Inc. 47
10.1.17 Pharmacyclics, Inc. 48
10.1.18 Immunovative Therapies, Ltd. 48
10.1.19 . Facet Biotech Corporation 49
10.1.20 ZIOPHARM Oncology, Inc. 49
11 Clinical Trial Profiles 50
11.1 Clinical Trial Overview of Top Institutes / Hospitals / Universities 50
11.1.1 National Cancer Institute (NCI) 50
11.1.2 The University of Texas M. D. Anderson Cancer Center 58
11.1.3 Fred Hutchinson Cancer Research Center-Technology Transfer 61
11.1.4 Mayo Clinic 65
11.1.5 University of Arkansas 67
11.1.6 Memorial Sloan Kettering Cancer Center 70
11.1.7 Sidney Kimmel Comprehensive Cancer Center 73
11.1.8 Roswell Park Cancer Institute 75
11.1.9 H. Lee Moffitt Cancer Center & Research Institute 76
11.1.10 Dana-Farber Cancer Institute 77
11.1.11 Southwest Oncology Group 78
11.1.12 University of California, San Francisco 80
11.1.13 Case Comprehensive Cancer Center 81
11.1.14 Eastern Cooperative Oncology Group 82
11.1.15 Barbara Ann Karmanos Cancer Institute 83
11.1.16 Beckman Research Institute 85
11.1.17 The Cancer and Leukemia Group B 86
11.1.18 Massachusetts General Hospital 87
11.1.19 The Vanderbilt-Ingram Cancer Center 88
11.1.20 National Heart, Lung, and Blood Institute 89
12 Appendix 90
12.1 Abbreviations 90
12.2 Definitions 90
12.3 Research Methodology 91
12.4 Secondary Research 91
12.5 About GlobalData 91
12.6 Contact Us 91
12.7 Disclaimer 92
12.8 Source 92
List of Tables
Table 1: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Zone, 1982-2010* 7
Table 2: Multiple Myeloma Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top Countries, 1982-2010* 9
Table 3: Multiple Myeloma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 1982-2010* 10
Table 4: Multiple Myeloma Therapeutics Clinical Trials, Europe, Top Five Countries, 1982-2010* 11
Table 5: Multiple Myeloma Therapeutics Clinical Trials, North America, Top Five Countries, 1982-2010* 12
Table 6: Multiple Myeloma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 1982-2010* 13
Table 7: Multiple Myeloma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 1982-2010* 14
Table 8: Multiple Myeloma Therapeutics Clinical Trials, BRIC Countries, 1982-2010* 15
Table 9: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Phase, 1982-2010* 16
Table 10: Multiple Myeloma Therapeutics Market, Global, Clinical Trials in Progress by Phase 1982-2010* 17
Table 11: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Trial Status, 1982-2010* 18
Table 12: Multiple Myeloma Therapeutics Market, Global, Suspended Clinical Trials, 1982-2010* 19
Table 13: Multiple Myeloma Therapeutics Market, Global, Terminated Clinical Trials, 1982-2010* 20
Table 14: Multiple Myeloma Therapeutics Market, Global, Terminated Clinical Trials, 1982-2010* 24
Table 15: Multiple Myeloma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 25
Table 16: Multiple Myeloma Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Table 17: Multiple Myeloma Therapeutics Clinical Trials, Global, Top Ten Companies by Phase, 1982-2010* 28
Table 18: Multiple Myeloma Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 1982-2010* 29
Table 19: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 1982-2010* 30
Table 20: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 1982-2010* 32
Table 21: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 1982-2010* 34
Table 22: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 1982-2010* 36
Table 23: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 1982-2010* 37
Table 24: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Vaxil Bio Therapeutics Ltd., 1982-2010* 38
Table 25: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 1982-2010* 39
Table 26: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Onyx Pharmaceuticals, Inc., 1982-2010* 40
Table 27: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceutica N.V., 1982-2010* 41
Table 28: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 1982-2010* 42
Table 29: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncotherapeutics, 1982-2010* 43
Table 30: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 1982-2010* 44
Table 31: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 1982-2010* 45
Table 32: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 1982-2010* 46
Table 33: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Innate Pharma SA , 1982-2010* 47
Table 34: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Poniard Pharmaceuticals, Inc., 1982-2010* 47
Table 35: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 1982-2010* 48
Table 36: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunovative Therapies, Ltd., 1982-2010* 48
Table 37: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Facet Biotech Corporation, 1982-2010* 49
Table 38: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by ZIOPHARM Oncology, Inc., 1982-2010* 49
Table 39: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 1982-2010* 50
Table 40: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 1982-2010* 58
Table 41: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 1982-2010* 61
Table 42: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 1982-2010* 65
Table 43: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 1982-2010* 67
Table 44: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 1982-2010* 70
Table 45: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 1982-2010* 73
Table 46: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 1982-2010* 75
Table 47: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 1982-2010* 76
Table 48: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 1982-2010* 77
Table 49: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 1982-2010* 78
Table 50: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 1982-2010* 80
Table 51: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 1982-2010* 81
Table 52: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 1982-2010* 82
Table 53: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 1982-2010* 83
Table 54: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beckman Research Institute, 1982-2010* 85
Table 55: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cancer and Leukemia Group B, 1982-2010* 86
Table 56: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 1982-2010* 87
Table 57: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Vanderbilt-Ingram Cancer Center, 1982-2010* 88
Table 58: Multiple Myeloma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 1982-2010* 89
List of Figures
Figure 1: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Zone (%), 1982-2010* 7
Figure 2: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Top Countries, 1982-2010* 8
Figure 3: Multiple Myeloma Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 1982-2010* 9
Figure 4: Multiple Myeloma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 1982-2010* 10
Figure 5: Multiple Myeloma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 1982-2010* 11
Figure 6: Multiple Myeloma Therapeutics Clinical Trials, North America, Top Five Countries (%), 1982-2010* 12
Figure 7: Multiple Myeloma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 1982-2010* 13
Figure 8 : Multiple Myeloma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 1982-2010* 14
Figure 9: Multiple Myeloma Therapeutics Clinical Trials, BRIC Countries (%), 1982-2010* 15
Figure 10: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Phase (%), 1982-2010* 16
Figure 11: Multiple Myeloma Therapeutics Market, Global, Clinical Trials in Progress by Phase, 1982-2010* 17
Figure 12: Multiple Myeloma Therapeutics Market, Global, Clinical Trials by Trial Status, 1982-2010* 18
Figure 13 : Multiple Myeloma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 25
Figure 14: Multiple Myeloma Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 26
Figure 15: Multiple Myeloma Therapeutics Clinical Trials, Global, Top Ten Companies by Phase, 1982-2010* 27
Figure 16: Multiple Myeloma Therapeutics Clinical Trials, Global, Clinical Trials in Progress by Prominent Drugs, 1982-2010* 29
Upcoming Reports:
|
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those in later stage of development.
The vaccines market has become high revenue generators despite being priced at a premium because of increasing occurrences of acute diseases and growing elderly population. The vaccine market has captured the attention of big pharmaceutical companies...
|
|
Remote Patient Monitoring Devices Market - Global Industry Size, Share, Analysis, Upcoming Technologies, Current Trends And Forecasts 2012 - 2018
By - Transparency Market Research
Global remote patient monitoring (RPM) devices market is forecasted to reach $556.9 million by the year 2016 at the compounded annual growth rate of 10% during the forecasted period. Some of the major factors responsible for this growth are continuously increasing number of patients suffering from chronic disorders like cardiovascular illnesses and diabetes and increasing number of elderly population, as these people often prefer house monitoring as it avoids travelling and waiting time. Cardiac remote patient monitoring is the largest segment of this industry and it is expected to...
|
|
Carrier Ethernet Equipment Market - Global Industry size, market share, trends, analysis and forecasts 2012 - 2018
By - Transparency Market Research
Carrier Ethernet equipment market is expected to grow at the compounded annual growth rate of 19.2 percent up to 2014. One of the key factors driving this market growth is the increasing adoption of IP based next generation networks. The US market for Carrier Ethernet equipments is also witnessing stupendous growth rate due to the increasing adoption of carrier Ethernet for mobile backhaul. However, rapid advancements in technology are posing major challenge to the growth of this market as it is encouraging end users to delay equipment purchase.
Increasing use of mobile...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
- Future of the Spanish Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
